Selonsertib is being developed by Gilead Sciences for the oral treatment of diabetic nephropathies, pulmonary arterial hypertension, kidney disorders and liver disorders.Reference standards of Selonsertib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Selonsertib - API Standards [catalogue_number] => PA 46 41000 [category_ids] => ,80,75,89,78,70,82, [chemical_name] => [weight] => 445.50 [form] => C24H24FN7O [cas] => 1448428-04-3 [pslug] => 1448428-04-3-selonsertib-api-pa4641000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 46 41000
CAS :
Molecular Formula : C24H24FN7O
Molecular Weight : 445.50
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....